BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14760125)

  • 1. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients.
    Biffi R; Pozzi S; Agazzi A; Pace U; Floridi A; Cenciarelli S; Peveri V; Cocquio A; Andreoni B; Martinelli G
    Ann Oncol; 2004 Feb; 15(2):296-300. PubMed ID: 14760125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
    Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
    Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device.
    Biffi R; Martinelli G; Pozzi S; Cinieri S; Cocorocchio E; Peccatori F; Ferrucci PF; Pistorio R; Andreoni B
    Bone Marrow Transplant; 1999 Jul; 24(1):89-93. PubMed ID: 10435741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Central venous totally implantable access for high dose chemotherapy in children].
    Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
    Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy.
    Bertoglio S; Cafiero F; Meszaros P; Varaldo E; Blondeaux E; Molinelli C; Minuto M
    J Vasc Access; 2020 Jul; 21(4):460-466. PubMed ID: 31674857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction.
    Ignatov A; Hoffman O; Smith B; Fahlke J; Peters B; Bischoff J; Costa SD
    Eur J Surg Oncol; 2009 Mar; 35(3):241-6. PubMed ID: 18329836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
    Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
    J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
    Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F
    Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral venous access ports: outcomes analysis in 109 patients.
    Bodner LJ; Nosher JL; Patel KM; Siegel RL; Biswal R; Gribbin CE; Tokarz R
    Cardiovasc Intervent Radiol; 2000; 23(3):187-93. PubMed ID: 10821892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally implantable ports connected to valved catheters for chemotherapy: experience from 350 Groshong devices.
    Nishinari K; Wolosker N; Bernardi CV; Yazbek G
    J Vasc Access; 2010; 11(1):17-22. PubMed ID: 20119917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of infections and complications in central venous catheters in adults with solid tumours.
    Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
    J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.
    Biffi R; De Braud F; Orsi F; Pozzi S; Arnaldi P; Goldhirsch A; Rotmensz N; Robertson C; Bellomi M; Andreoni B
    Cancer; 2001 Sep; 92(5):1204-12. PubMed ID: 11571734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jugular versus subclavian totally implantable access ports: catheter position, complications and intrainterventional pain perception.
    Plumhans C; Mahnken AH; Ocklenburg C; Keil S; Behrendt FF; Günther RW; Schoth F
    Eur J Radiol; 2011 Sep; 79(3):338-42. PubMed ID: 20227211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.
    D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Al-Baimani K; Hamid RS; Mittal AK; Al-Balushi M; Burney IA; Al-Moundhri MS
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e103-e109. PubMed ID: 33777430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
    Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H
    Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy.
    Sehirali S; Inal MM; Ozsezgin S; Sanci M; Atli O; Nayki C; Yildirim Y; Tinar S
    Int J Gynecol Cancer; 2005; 15(2):228-32. PubMed ID: 15823104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.